89 related articles for article (PubMed ID: 21216005)
1. Immunohistochemical expression of Annexin A5 in preeclamptic placentas.
Ornaghi S; Vergani P; Urban G; Giardini V; Moltrasio F; Leone BE
Placenta; 2011 Mar; 32(3):264-8. PubMed ID: 21216005
[TBL] [Abstract][Full Text] [Related]
2. Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas.
Jeschke U; Mayr D; Schiessl B; Mylonas I; Schulze S; Kuhn C; Friese K; Walzel H
Placenta; 2007; 28(11-12):1165-73. PubMed ID: 17664004
[TBL] [Abstract][Full Text] [Related]
3. Investigation of role of vascular endothelial growth factor, Annexin A5 and Apelin by immunohistochemistry method in placenta of preeclampsia patients.
Colcimen N; Bulut G; Ergul Erkec O; Ragbetli MC
Cell Mol Biol (Noisy-le-grand); 2017 Nov; 63(11):42-45. PubMed ID: 29208172
[TBL] [Abstract][Full Text] [Related]
4. Annexin V expression in human placenta is influenced by the carriership of the common haplotype M2.
Chinni E; Tiscia GL; Colaizzo D; Vergura P; Margaglione M; Grandone E
Fertil Steril; 2009 Mar; 91(3):940-2. PubMed ID: 18462735
[TBL] [Abstract][Full Text] [Related]
5. Expression of cellular prion protein in the placentas of women with normal and preeclamptic pregnancies.
Hwang HS; Park SH; Park YW; Kwon HS; Sohn IS
Acta Obstet Gynecol Scand; 2010 Sep; 89(9):1155-61. PubMed ID: 20804341
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of annexin V expression in placentae of preeclampsia.
Shu F; Sugimura M; Kanayama N; Kobayashi H; Kobayashi T; Terao T
Gynecol Obstet Invest; 2000; 49(1):17-23. PubMed ID: 10629367
[TBL] [Abstract][Full Text] [Related]
7. Placental expression of syndecan 1 is diminished in preeclampsia.
Jokimaa VI; Kujari HP; Ekholm EM; Inki PL; Anttila L
Am J Obstet Gynecol; 2000 Dec; 183(6):1495-8. PubMed ID: 11120517
[TBL] [Abstract][Full Text] [Related]
8. Reduced ANXA5 mRNA and protein expression in pregnancies complicated by preeclampsia.
Gourvas V; Soulitzis N; Konstantinidou A; Dalpa E; Koukoura O; Koutroulakis D; Spandidos DA; Sifakis S
Thromb Res; 2014 Mar; 133(3):495-500. PubMed ID: 24393658
[TBL] [Abstract][Full Text] [Related]
9. Cytokine-related genes and oxidation-related genes detected in preeclamptic placentas.
Lee GS; Joe YS; Kim SJ; Shin JC
Arch Gynecol Obstet; 2010 Oct; 282(4):363-9. PubMed ID: 19787364
[TBL] [Abstract][Full Text] [Related]
10. Placental localization and expression of the cell death factors BNip3 and Nix in preeclampsia, intrauterine growth retardation and HELLP syndrome.
Stepan H; Leo C; Purz S; Höckel M; Horn LC
Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):172-6. PubMed ID: 16219518
[TBL] [Abstract][Full Text] [Related]
11. Proteasomal activity in placentas from women with preeclampsia and intrauterine growth restriction: implications for expression of HIF-alpha proteins.
Rajakumar A; Michael HM; Daftary A; Jeyabalan A; Gilmour C; Conrad KP
Placenta; 2008 Mar; 29(3):290-9. PubMed ID: 18222538
[TBL] [Abstract][Full Text] [Related]
12. Release of inositol phosphoglycan P-type by the human placenta following insulin stimulus: a multiple comparison between preeclampsia, intrauterine growth restriction, and gestational hypertension.
Scioscia M; Paine MA; Gumaa K; Rodeck CH; Rademacher TW
J Matern Fetal Neonatal Med; 2008 Aug; 21(8):581-5. PubMed ID: 18609357
[TBL] [Abstract][Full Text] [Related]
13. [Proliferation of villous trophoblast and stroma in normal and pathologic pregnancies (preeclampsia)].
Staribratova D; Zaprianov Z; Milchev N
Akush Ginekol (Sofiia); 2005; 44(2):20-2. PubMed ID: 15853022
[TBL] [Abstract][Full Text] [Related]
14. The immunohistochemical evaluation of VEGF in placenta biopsies of pregnancies complicated by preeclampsia.
Akercan F; Cirpan T; Terek MC; Ozcakir HT; Giray G; Sagol S; Karadadas N
Arch Gynecol Obstet; 2008 Feb; 277(2):109-14. PubMed ID: 17710429
[TBL] [Abstract][Full Text] [Related]
15. Expression of heat shock protein 70 and endothelial nitric oxide synthase in placental tissue of preeclamptic and intrauterine growth-restricted pregnancies.
Barut F; Barut A; Dogan Gun B; Kandemir NO; Aktunc E; Harma M; Harma MI; Ozdamar SO
Pathol Res Pract; 2010 Sep; 206(9):651-6. PubMed ID: 20478661
[TBL] [Abstract][Full Text] [Related]
16. Second trimester amniotic fluid annexin A5 levels and subsequent development of intrauterine growth restriction.
Dundar O; Yoruk P; Tutuncu L; Muhcu M; Ipcioglu O; Ergur AR; Mungen E
Prenat Diagn; 2008 Oct; 28(10):887-91. PubMed ID: 18792921
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of thioredoxin and glutaredoxin in placentae from pregnancies with pre-eclampsia and intrauterine growth restriction.
Sahlin L; Ostlund E; Wang H; Holmgren A; Fried G
Placenta; 2000 Sep; 21(7):603-9. PubMed ID: 10985961
[TBL] [Abstract][Full Text] [Related]
18. Expression of the proliferation marker Ki-67 and of p53 tumor protein in trophoblastic tissue of preeclamptic, HELLP, and intrauterine growth-restricted pregnancies.
Jeschke U; Schiessl B; Mylonas I; Kunze S; Kuhn C; Schulze S; Friese K; Mayr D
Int J Gynecol Pathol; 2006 Oct; 25(4):354-60. PubMed ID: 16990712
[TBL] [Abstract][Full Text] [Related]
19. Decreased annexin A5 mRNA placental expression in pregnancies complicated by fetal growth restriction.
Sifakis S; Soufla G; Koukoura O; Soulitzis N; Koutroulakis D; Maiz N; Konstantinidou A; Melissari E; Spandidos DA
Thromb Res; 2010 Apr; 125(4):326-31. PubMed ID: 20034656
[TBL] [Abstract][Full Text] [Related]
20. [Differential expression of adrenomedullin in the placentas of women with normal and preeclamptic pregnancies in late term].
Gao YF; Yu YH; Li ZQ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1828-30. PubMed ID: 17259131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]